Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway

Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway

Glioblastoma (GBM) is a human malignant tumor with low survival and high recurrence rate. Angelicin, an active furanocoumarin compound, has been reported to possess potential antitumor activity towards various malignancies. However, the effect of angelicin on GBM cells and its mechanism are still un...

Full description

Bibliographic Details
Main Authors: Mengmeng Wang, Shuqiao Xing, Jiamei Jia, Weiquan Zeng, Jia Lei, Yiming Qian, Zhenrong Xiong, Xin Wang, Liying Cao, Yongjie Wang, Ying Wang, Yuanyuan Jiang, Zhihui Huang
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Angelicin
GBM
YAP
Proliferation
Cell cycle
Migration
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223002500

Similar Items

Similar Items